Serum carnitine levels and levocarnitine supplementation in institutionalized Huntington’s disease patients

Levocarnitine for valproic-acid-induced hyperammonemic encephalopathy

(2011) C. M. Mock et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial

(2011) Michele Malaguarnera et al.   METABOLIC BRAIN DISEASE

Acetyl-l-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy

(2011) Mariano Malaguarnera et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Clinical Outcomes and Low-Dose Levocarnitine Supplementation in Psychiatric Inpatients With Documented Hypocarnitinemia: A Retrospective Chart Review

(2010) Miroslav Cuturic et al.   Journal of Psychiatric Practice

Clinical correlates of low serum carnitine levels in hospitalized psychiatric patients

(2010) Miroslav Cuturic et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Neuroprotective effects of L-carnitine in a transgenic animal model of Huntington's disease

(2009) Eniko Vamos et al.   BIOMEDICINE & PHARMACOTHERAPY

Effects of simvastatin and carnitine versus simvastatin on lipoprotein(a) and apoprotein(a) in type 2 diabetes mellitus

(2009) Fabio Galvano et al.   EXPERT OPINION ON PHARMACOTHERAPY

Effect of l-carnitine on the size of low-density lipoprotein particles in type 2 diabetes mellitus patients treated with simvastatin

(2009) Mariano Malaguarnera et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

l-Carnitine supplementation reduces oxidized LDL cholesterol in patients with diabetes

(2008) Mariano Malaguarnera et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Acetyl-l-Carnitine Treatment in Minimal Hepatic Encephalopathy

(2008) Mariano Malaguarnera et al.   DIGESTIVE DISEASES AND SCIENCES